134 related articles for article (PubMed ID: 2559036)
1. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.
Maton PN
Gastroenterol Clin North Am; 1989 Dec; 18(4):897-922. PubMed ID: 2559036
[TBL] [Abstract][Full Text] [Related]
2. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
3. Use of octreotide acetate for control of symptoms in patients with islet cell tumors.
Maton PN
World J Surg; 1993; 17(4):504-10. PubMed ID: 8395751
[TBL] [Abstract][Full Text] [Related]
4. Islet cell tumors.
Stabile BE
Gastroenterologist; 1997 Sep; 5(3):213-32. PubMed ID: 9298376
[TBL] [Abstract][Full Text] [Related]
5. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
Ben Yosef R; Glaser B; Catane R
Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
[TBL] [Abstract][Full Text] [Related]
6. Octreotide--a synthetic somatostatin.
Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
[No Abstract] [Full Text] [Related]
7. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
[TBL] [Abstract][Full Text] [Related]
9. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
[TBL] [Abstract][Full Text] [Related]
10. Management of unresectable malignant endocrine tumors of the pancreas.
Modlin IM; Lewis JJ; Ahlman H; Bilchik AJ; Kumar RR
Surg Gynecol Obstet; 1993 May; 176(5):507-18. PubMed ID: 8386860
[TBL] [Abstract][Full Text] [Related]
11. Vipoma, glucagonoma and the role of Sandostatin.
Bloom SR
NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
[No Abstract] [Full Text] [Related]
12. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
[TBL] [Abstract][Full Text] [Related]
13. A case of somatostatinoma: responses to food and SMS 201-995 administration.
Davis TM; Bray G; Domin J; Bloom SR
Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
[TBL] [Abstract][Full Text] [Related]
14. An important new treatment for carcinoid tumors and VIPomas.
Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315
[No Abstract] [Full Text] [Related]
15. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogues in the management of benign insulinomas.
Laron Z
Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
[No Abstract] [Full Text] [Related]
17. Octreotide, a new somatostatin analogue.
Katz MD; Erstad BL
Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
[TBL] [Abstract][Full Text] [Related]
18. The role of surgery in the management of islet cell tumors.
Fraker DL; Norton JA
Gastroenterol Clin North Am; 1989 Dec; 18(4):805-30. PubMed ID: 2559034
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine-active gastrointestinal tumors: are there any new therapeutic possibilities?].
Marbet UA; Kraenzlin M; Gyr K; Stalder GA
Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1120-3. PubMed ID: 2426077
[No Abstract] [Full Text] [Related]
20. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
